Further reading

Reviews on classification, diagnosis and treatment of ILD

  • American Thoracic Society, European Respiratory Society. ATS/ERS International Consensus Statement. Idiopathic pulmonary fibrosis: diagnosis and treatment. Am J Respir Crit Care Med 2000; 161: 646–664.
  • du Bois RM, Richeldi L, eds. Interstitial Lung Diseases. Eur Respir Monogr 2009; 46.
  • Travis WD, King TE, Bateman ED, et al. ATS-ERS international multidisciplinaryconsensus classification of idiopathic interstitial pneumonias. General principles andrecommendations. Am J Respir Crit Care Med 2002; 165: 277–304.
  • Wells AU, Hirani N. Interstitial lung disease guideline: the British Thoracic Society incollaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 2008; 63: Suppl. V, v1–v58.


  • Agostini C, Albera C, Bariffi F, et al. First report of the Italian register for diffuse infiltrative lung disorders (RIPID). Monaldi Arch Chest Dis 2001; 56: 364–368.
  • Bourke SJ, Dalphin JC, Boyd G, et al. Hypersensitivity pneumonitis: current concepts. Eur Respir J 2001; 18: Suppl. 32, 81s–92s.
  • Gribbin J, Hubbard RB, Le Jeune I, et al. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax 2006; 61: 980–985.
  • Hansell A, Hollowell J, Nichols T, et al. Use of the General Practice Research Database (GPRD) for respiratory epidemiology: a comparison with the 4th Morbidity Survey in General Practice (MSGP4). Thorax 1999; 54: 413–419.
  • Hubbard R, Johnston I, Coultas DB, et al. Mortality rates from cryptogenic fibrosing alveolitis in seven countries. Thorax 1996; 51: 711–716.
  • Karakatsani A, Papakosta D, Rapti A, et al. Epidemiology of interstitial lung diseases in Greece. Respir Med 2009; 103: 1122–1129.
  • Kornum JB, Christensen S, Grijota M, et al. The incidence of interstitial lung disease 1995–2005: a Danish nationwide population-based study. BMC Pulmon Med 2008; 8: 24–30.
  • Lopez-Campos JL, Rodriguez-Becerra E. Incidence of interstitial lung diseases in the south of Spain 1998-2000: the RENIA study. Eur J Epidemiol 2004; 19: 155–161.
  • Navaratnam V, Fleming KM, West J, et al. The rising incidence of idiopathic pulmonary fibrosis in the UK. Thorax 2011; 66: 462–467.
  • Solaymani-Dodaran M, West J, Smith C, et al. Extrinsic allergic alveolitis: incidence in the general population. Q J Med 2007; 100: 233–237.
  • Thomeer MJ, Costabel U, Rizzato G, et al. Comparison of registries of interstitial lung diseases in three European countries. Eur Respir J 2001; 18: Suppl. 32, 114s–118s.
  • von Plessen C, Grinde O, Gulsvik A. Incidence and prevalence of cryptogenic fibrosing alveolitis in a Norwegian community. Respir Med 2003; 97: 428–435.
  • Xaubet A, Ancochea J, Morel F, et al. Report on the incidence of interstitial lung diseases in Spain. Sarcoidosis Vasc Diff Lung Dis 2004; 21: 64–70.

See the entire Interstitial lung diseases Chapter